|
Jun 20
|
Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?
|
|
Jun 12
|
BMY Reports Positive Data on Sotyktu From Arthritis Study
|
|
Jun 12
|
Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025
|
|
Jun 12
|
Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025
|
|
Jun 11
|
Bristol-Myers Squibb (NYSE:BMY) Reports Positive Phase 3 Trial Results For Sotyktu
|
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
|
Jun 11
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
Jun 11
|
Bristol Myers bolsters radiopharma portfolio with PhiloChem deal
|
|
Jun 11
|
Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis
|
|
Jun 10
|
Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royal...
|
|
Jun 9
|
Bristol Myers Squibb (BMY) Exceeds Market Returns: Some Facts to Consider
|
|
Jun 9
|
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy?
|
|
Jun 9
|
Acquisitions, Licensing Deals Take Centerstage in Pharma/Biotech Space
|
|
Jun 8
|
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
|
|
Jun 7
|
Patents and economies of scale support Pfizer's wide moat
|
|
Jun 6
|
Markey Researchers Awarded $6.8 Million To Help Others Replicate Kentucky's Lung Cancer Screening Success
|
|
Jun 6
|
Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?
|
|
Jun 6
|
BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?
|
|
Jun 6
|
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers
|
|
May 28
|
Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
|